News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novo Nordisk A/S (NVO) Increased Operating Profit In Local Currencies By 15% In 2013



1/30/2014 8:51:36 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BAGSVAERD, Denmark, Jan. 30, 2014 (GLOBE NEWSWIRE) -- Sales growth of 12% in local currencies driven by growth in sales of Victoza®, NovoRapid® and Levemir®

Sales increased by 12% in local currencies and by 7% to 83.6 billion in Danish kroner.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES